2 Biotech Stocks Poised to Soar in 2021
In your portfolio, you probably have a few stocks that you consider to be relatively safe, and a few that you think might be on the riskier side -- which could reward you with a faster rate of growth. Assuming that your portfolio is balanced and sufficiently diversified, it's not a bad idea to invest in small-cap stocks that could drive big returns.
Today, I'll be discussing a pair of biotech stocks that are toward the riskier end of the spectrum, so buckle up. Neither of these companies have a product yet, and their revenue is dependent on drug development agreements with larger collaborators. However, this year will likely send both stocks into overdrive -- assuming that everything goes as planned.
Image source: Getty Images.
Source Fool.com